BRD2 and infection: For blood borne viruses including HIV, HBV, and HCV, NAT exhibits enhanced sensitivity in identifying window-period infections and low-level viremia in donor specimens, providing critical complementation to the diagnostic gaps inherent in ELISA-based serological screening.